Bioanalytics
Characterizing the biological effects of a drug product is vital for its development into a safe and effective advanced therapy. Efficient and effective evaluation of immunogenicity, biodistribution, viral shedding, and biomarkers enable the establishment of dosing regimens, the validation of targets, and the identification of potential toxicity. Franklin Biolabs is here to help assess your genetic medicine through the preclinical and clinical stages.
Our Expertise
Our immunology core is a reference lab available to the global community to evaluate humoral and cellular host immune responses before and after advanced therapy administration. Franklin Biolabs also offers a wide array of robust and sensitive assays for evaluating biodistribution and biomarkers for genetic medicines. Our team of experts can guide the selection or development of appropriate, meaningful analytes to comprehensively characterize your genetic medicine, with a variety of standard, custom, and GLP-compliant options available.
Served >75 companies and institutions
Supported more than
40 clinical trials
Performed >25,000 preclinical and
>2,400 clinical assays over the last 5 years
Our Services
Biodistribution/Shedding
Quantitative gene expression by qPCR across numerous matrices
Validated assays for GLP programs
Biomarkers/Protein Expression
Mass Spectrometry
ELISA
Meso Scale Discovery (MSD)
Immunogenicity
Learn more about our Immunology core services here
